Funder: National Institutes of Health
Due Dates: September 13, 2024 | January 13, 2025 | May 13, 2025 | September 15, 2025 | January 13, 2026 | May 13, 2026 | September 14, 2026 | January 13, 2027 (see full list for AIDS and non-AIDS cycles)
Funding Amounts: Up to $1,000,000 total costs per year for up to 3 years (Phase II/IIB); Fast-Track Phase I up to $300,000/year for up to 2 years; budgets must be well justified and may exceed these caps for approved topics.
Summary: Supports U.S. small businesses to conduct investigator-initiated, milestone-driven clinical trials aligned with NIAID’s mission, with emphasis on high-risk studies and non-routine interventions.
Key Information: Prior consultation with NIAID at least 10 weeks before the deadline is strongly encouraged; all clinical trial planning must be complete at submission; only one clinical trial per application.